XYL - Company ID 0001524472
The table below shows Xylem Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.13B | $2.27B | $2.30B | $2.07B | $2.10B | $2.17B |
| Cost of revenue | $1.32B | $1.39B | $1.41B | $1.30B | $1.32B | $1.35B |
| Gross profit | $803.00M | $883.00M | $892.00M | $768.00M | $784.00M | $819.00M |
| R&D | $56.00M | $52.00M | $58.00M | $56.00M | $55.00M | $58.00M |
Xylem Inc. reported annual revenue of $9.04B for fiscal year 2025. That is up 5.5% from $8.56B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $3.77B (FY 2016) to $9.04B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $472.00M | $474.00M | $503.00M | $460.00M | $445.00M | $485.00M |
| Operating income | $244.00M | $334.00M | $305.00M | $231.00M | $280.00M | $253.00M |
| Income tax | $55.00M | $71.00M | $75.00M | $50.00M | $52.00M | $53.00M |
| Net income | $193.00M | $227.00M | $226.00M | $169.00M | $217.00M | $194.00M |
| EPS (diluted) | $0.79 | $0.93 | $0.93 | $0.69 | $0.89 | $0.80 |